Gil Morgan, MD
@weoncologists
Clinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏
ID:39742016
13-05-2009 12:44:05
18,2K Tweets
16,3K Followers
7,7K Following
Follow People
It was fantastic to see you Gil Morgan OncoAlert and spend amazing time in Athens with Giuseppe Banna Jarushka Naidoo Marita Lykka MD Marinos Tsiatas & others! Thanks Giannis Mountzios for the invitation & great hospitality! ΕΟΠΕ is doing great work in Greece! Hope for more meetings in Athens!
Ryan Hughes at presidential: a nice framework for thinking about toxicity/QoL assessment ⬇️. Did you know in an EORTC review of >200 trials, >60% had significant differences in PROs, ~75% of which were in global domains? ➡️ bit.ly/3gAldBr - #ASTRO2022 #radonc OncoAlert
Wonderful time in Athens with friends! Enjoying lunch, discussing about oncology & getting ready for my talk on #bladdercancer Marinos Tsiatas Gil Morgan OncoAlert Giannis Mountzios Marita Lykka MD Myrto K. Moutafi MikaLion Anastasios Boutis ΕΛΛΟΚ Shilpa Gupta Dr. Bishoy M. Faltas Bladder Cancer Advocacy Network
Honored to #StandWithUkraine️ and these amazing #womenwhocurie . See u at the Special Session on Ukraine at 2 pm
Erin Gillespie, MD presents a provocative phase II RCT of prophylactic #radiotherapy to asymptomatic but high risk bone Mets. N=93 Convincing home run, 29% vs 1.6% skeletal related events, with an ⬆️ OS benefit! Remained significant on MVA #ASTRO22 #OncoAlert
#ASTRO22 Clinical Trials #2
Dr. Tamim Niazi showing that moderate hypofrac (68/25) for high risk #prostatecancer is similar to low/int risk populations #pcsm OncoAlert
↔️ similar cancer outcomes - 7 yr OS, PCSM, BFFS, DMFS
⬆️ acute GU/GI tox, with no differences in late effects
Great discussion of this morning’s Clinical Trials #prostatecancer abstracts by Sophia Kamran, MD
#ASTRO22 OncoAlert #pcsm